- Profile
- Personal Information
- Publications
Experts in Pharmaceutical Sciences
Rabaa M. Al-Rousan Hamed I. Aly Daniela Z. Bazan Adam Brown Wei Minjie Juan F. Castro Dr. Manoj Kumar Barthwal Dr Jagavelu Kumaravelu Zakaria Abd Elmageed Burton M Altura BENJAMIN E. BLASS Charlotte Farris Michael Borenstein prof. dr. A.J.R. Heck Vibha Rani Reza Fassihi Shweta Dang MARC ILIES Adriana Ribeiro Silva SWATI NAGAR View MoreKEVIN KENNEDY
Senior Vice President
pharmaceutic
NASDAQ
Cambodia
Kevin Kennedy is Senior Vice President and Head of U.S. Options in Nasdaq’s Global Trading & Market Services business. In this role, Mr. Kennedy is responsible for leading the US Options business for Nasdaq, including setting the strategic direction for all six of Nasdaq’s U.S. Options exchanges. Prior to his appointment as Head of U.S. Options, he served as Head of Market Operations for U.S. Options at Nasdaq. Mr. Kennedy also served on the Board of Governors of the PHLX prior to its acquisition by Nasdaq. Mr. Kennedy began his career as an independent market maker in September 1987. Since then, he has served as President of his own trading firm, and Vice President in Goldman Sachs Equities division, where he managed the firm’s Philadelphia derivatives operation. Mr. Kennedy graduated from La Salle University in 1987 with a Bachelor of Science in Finance.
Science